Chen Maobo: Over the past two years, more than 80 innovative technology companies have settled in Hong Kong.

Financial Secretary of Hong Kong, Paul Chan Mo-po, attended a biotech investment summit and stated that the biotech field has unlimited opportunities. China is currently the world's second-largest biopharmaceutical market and is rising to become a leader in biotechnology. Hong Kong can serve as a gateway to enter the mainland market and a platform for mainland innovative achievements to reach the world. Chan Mo-po pointed out that Hong Kong has many advantages and can be a reliable and trustworthy partner for technology development and investment cooperation. Currently, Hong Kong has 4,700 start-up companies and nearly 20 unicorn companies, many of which have been cultivated and supported by the Science Park and Cyberport. The government will continue to attract policy-oriented companies from around the world, and over the past two years, more than 80 innovative technology companies have settled in Hong Kong, investing over $6.5 billion and providing about 20,000 high-quality jobs.